Possible Founder Effect of the {CDKN}2A c.146T{\textgreater}C Variant in the Mexican Population: Phenotypic Characterization

Garza Rodríguez, María Lourdes y Vargas Márquez, Eren Adrián Alejandro y Aguilar, Dione y Trujillo Bornios, Samantha y Gallardo Blanco, Hugo Leonid y Vidal Gutiérrez, Oscar y Pérez Ibave, Diana Cristina y Burciaga Flores, Carlos Horacio (2026) Possible Founder Effect of the {CDKN}2A c.146T{\textgreater}C Variant in the Mexican Population: Phenotypic Characterization. Genes, 17 (5). pp. 1-11. ISSN 2073-4425

[img]
Vista previa
Texto
31459.pdf - Versión Publicada
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (391kB) | Vista previa

Resumen

Background: Germline {CDKN}2A variants are associated with Familial Atypical Mole-Malignant Melanoma ({FAMMM}) syndrome. This syndrome involves an increased risk of melanoma, pancreatic cancer, and, in specific populations, duodenal cancer, breast cancer, and astrocytoma. The {CDKN}2A (c.146T{\textgreater}C) variant has been found in hereditary cancer patients within the Mexican population. Furthermore, the phenotype linked to this variant in Mexico differs from that observed in other groups. This study aims to evaluate the founder effect of the {CDKN}2A (c.146T{\textgreater}C) variant through epidemiological analysis and to describe the phenotype within our population. Patients and Methods: We examined 72 Mexican patients (14 probands from distinct families, 48 relatives, and 10 nonrelated probands) carrying the {CDKN}2A (c.146T{\textgreater}C) form three hereditary cancer centers between September 2023 and September 2025. Results: Of the 72 individuals analyzed, 52 (72.22\%) tested positive. A cancer diagnosis was established in 27 (37.50\%) of the individuals analyzed. Breast cancer was the most common neoplasia, accounting for 19 cases (70.37\%), followed by melanoma with 4 cases (14.81\%) and ovarian cancer with 2 cases (7.40\%). Three patients (11.11\%) had two distinct primary neoplasms. Conclusions: Based on our findings and the fact that this variant has been reported nearly exclusively in the Mexican population, we conclude that it has a founder effect in this population. Additionally, the phenotype associated with this variant can vary among populations, with breast cancer being the most common carcinoma rather than melanoma among Mexican carriers, highlighting the importance of updating screening guidelines.

Tipo de elemento: Article
Palabras claves no controlados: Posible efecto fundador de la variante c.146T<sub>C</sub> del gen CDKN2A en la población mexicana: caracterización fenotípica CDKN2A; Cáncer de mama; Efecto fundador; Variante germinal; Cáncer hereditario
Materias: R Medicina > RC Medicina Interna, Psiquiatría, Neurología
Divisiones: Medicina > Maestría en Ciencias con Orientación en Biología Molecular e Ingeniería Genética
Usuario depositante: Dr.C. Hugo Gallardo Blanco
Creadores:
CreadorEmailORCID
Garza Rodríguez, María Lourdesmaria.garzarg@uanl.edu.mxorcid.org/0000-0001-7096-2713
Vargas Márquez, Eren Adrián AlejandroNO ESPECIFICADOorcid.org/0009-0001-2572-7076
Aguilar, DioneNO ESPECIFICADONO ESPECIFICADO
Trujillo Bornios, SamanthaNO ESPECIFICADONO ESPECIFICADO
Gallardo Blanco, Hugo Leonidhugo.gallardobl@uanl.edu.mxorcid.org/0000-0002-7816-4967
Vidal Gutiérrez, Oscaroscar.vidalgtz@uanl.edu.mxorcid.org/0000-0003-3723-8525
Pérez Ibave, Diana Cristinadperezi@uanl.edu.mxorcid.org/0000-0002-7816-4967
Burciaga Flores, Carlos Horaciocarlos.hburciaga@gmail.comorcid.org/0000-0002-7723-8354
Fecha del depósito: 23 Jun 2026 16:17
Última modificación: 23 Jun 2026 16:17
URI: http://eprints.uanl.mx/id/eprint/31459

Actions (login required)

Ver elemento Ver elemento

Downloads

Downloads per month over past year